(1 reference)Kurzübersicht für Maus anti-Human IgM Antikörper (FITC) (ABIN2474848)
Target
Klonalität
Konjugat
Applikation
Klon
Isotyp
-
-
Reaktivität
- Human
-
Wirt
- Maus
-
Produktmerkmale
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
-
-
Mouse anti-Human IgM antibody (FITC)
FACS Monoclonal CH2 IgG1 kappa FITC
Mouse anti-Human IgM antibody (APC)FACS Monoclonal CH2 IgG1 kappa APC
Mouse anti-Human IgM antibody (PE)FACS Monoclonal CH2 IgG1 kappa PE
Goat anti-Human IgM (Heavy Chain) antibody (TRITC)ELISA, FACS, IHC Polyclonal IgG TRITC
Goat anti-Human IgM (Heavy Chain) antibody (FITC)ELISA, FACS, IHC Polyclonal IgG FITC
Mouse anti-Human IgM antibody (iFluor™647)GMP Grade FACS Monoclonal M-2E6 IgG1 iFluor™647
Mouse anti-Human IgM antibody (iFluor™700)GMP Grade FACS Monoclonal M-2E6 IgG1 iFluor™700
Mouse anti-Human IgM antibody (mFluor™450)GMP Grade FACS Monoclonal M-2E6 IgG1 mFluor™450
Mouse anti-Human IgM antibody (PE-Cy7)GMP Grade FACS Monoclonal M-2E6 IgG1 PE-Cy7
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.1 mg/mL
-
-
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
- IgM
-
Substanzklasse
- Antibody
-
Gen-ID
- 3507
-
UniProt
- P01871
Target
-
